Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci186652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Hayley E McMorrow und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine. Hauptthemen laut MEDLINE: Agouti-Related Protein, Neurons, Eating, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH, American Diabetes Association.
Abstract (Originalsprache)
The incretin receptor agonists semaglutide and tirzepatide have transformed the medical management of obesity. The neural mechanisms by which incretin analogs regulate appetite remain incompletely understood, and dissecting this process is critical for the development of next-generation antiobesity drugs that are more targeted and tolerable. Moreover, the physiologic functions of incretins in appetite regulation and gut-brain communication have remained elusive. Using in vivo fiber photometry, we discovered distinct pharmacologic and physiologic roles for the incretin hormones glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). We showed that GIP, but not GLP-1, was required for normal nutrient-mediated inhibition of hunger-promoting AgRP neurons. By contrast, both GIP and GLP-1 analogs at pharmacologic doses were sufficient to inhibit AgRP neurons. The magnitude of neural inhibition was proportional to the effect of each incretin on food intake, and dual GIP and GLP-1 receptor agonism more potently inhibited AgRP neurons and suppressed food intake than either agonist alone. Our results have revealed a role for endogenous GIP in gut-brain appetite regulation and indicate that incretin analogs act in part via AgRP neurons to mediate their anorectic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine.
- Interdepartmental Neuroscience Graduate Program, and.
- Driskill Graduate Program in Life Sciences, Northwestern University, Chicago, Illinois, USA.
- Department of Neuroscience, Northwestern University, Chicago, Illinois, USA.
- Diabetes, Obesity and Complications Therapeutic Area, Eli Lilly, Indianapolis, Indiana, USA.
Förderung
- NIDDK NIH HHS
- NIH
- American Diabetes Association
Zitieren
APA
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025). Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci186652
Vancouver
McMorrow HE, Cohen AB, Lorch CM, Hayes NW, Fleps SW, Frydman JA, et al. Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci186652
BibTeX
@article{McMorrow2025,
author = {McMorrow, Hayley E and Cohen, Andrew B and Lorch, Carolyn M and Hayes, Nikolas W and Fleps, Stefan W and Frydman, Joshua A and Xia, Jessica L and Samms, Ricardo J and Beutler, Lisa R},
title = {Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci186652}
}
EUVIMED